Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-85

I know right?! Especially given they explicitly referenced it March 17. Weird.

“The results from the extended, repeat Study 2 confirm the results from Study 1, showing a
clear clinical benefit from the treatment with BIT225.
Supported by these results, and in consultation with USA based advisors and consultants,
Biotron has submitted a proposal to the USA Food and Drug Administration (FDA) to conduct
a human clinical trial to assess the efficacy of BIT225 for the treatment of COVID-19 under
the Coronavirus Treatment Acceleration Program, a special emergency program for potential
coronavirus therapies.
Funding the clinical development of BIT225 for this indication will be sought from potential
partners and non-equity funding sources.”

https://hotcopper.com.au/threads/ann-bit225-effectiveness-against-covid-19-in-animals.6646745/